119 related articles for article (PubMed ID: 10638392)
1. Arterial/venous plasma nicotine concentrations following nicotine nasal spray.
Guthrie SK; Zubieta JK; Ohl L; Ni L; Koeppe RA; Minoshima S; Domino EF
Eur J Clin Pharmacol; 1999 Nov; 55(9):639-43. PubMed ID: 10638392
[TBL] [Abstract][Full Text] [Related]
2. Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine.
Gourlay SG; Benowitz NL
Clin Pharmacol Ther; 1997 Oct; 62(4):453-63. PubMed ID: 9357397
[TBL] [Abstract][Full Text] [Related]
3. Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking.
Benowitz NL; Zevin S; Jacob P
Br J Clin Pharmacol; 1997 Mar; 43(3):259-67. PubMed ID: 9088580
[TBL] [Abstract][Full Text] [Related]
4. Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers.
Domino EF; Minoshima S; Guthrie S; Ohl L; Ni L; Koeppe RA; Zubieta JK
Synapse; 2000 Dec; 38(3):313-21. PubMed ID: 11020234
[TBL] [Abstract][Full Text] [Related]
5. Effects of nicotine patch or nasal spray on nicotine and cotinine concentrations in pregnant smokers.
Oncken C; Campbell W; Chan G; Hatsukami D; Kranzler HR
J Matern Fetal Neonatal Med; 2009 Sep; 22(9):751-8. PubMed ID: 19526424
[TBL] [Abstract][Full Text] [Related]
6. Rate of nicotine onset from nicotine replacement therapy and acute responses in smokers.
Perkins KA; Lerman C; Keenan J; Fonte C; Coddington S
Nicotine Tob Res; 2004 Jun; 6(3):501-7. PubMed ID: 15203784
[TBL] [Abstract][Full Text] [Related]
7. Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia.
Smith RC; Singh A; Infante M; Khandat A; Kloos A
Neuropsychopharmacology; 2002 Sep; 27(3):479-97. PubMed ID: 12225705
[TBL] [Abstract][Full Text] [Related]
8. An oral formulation of nicotine for release and absorption in the colon: its development and pharmacokinetics.
Green JT; Evans BK; Rhodes J; Thomas GA; Ranshaw C; Feyerabend C; Russell MA
Br J Clin Pharmacol; 1999 Oct; 48(4):485-93. PubMed ID: 10583017
[TBL] [Abstract][Full Text] [Related]
9. Nicotine, cotinine, withdrawal, and craving patterns during smoking and nicotine nasal spray use: results from a pilot study with African American men.
Mabry PL; Tooze JA; Moser RP; Augustson EM; Malcolm RJ; Benowitz NL
Nicotine Tob Res; 2007 Jan; 9(1):65-82. PubMed ID: 17365738
[TBL] [Abstract][Full Text] [Related]
10. Plasma nitric oxide before and after smoking cessation with nicotine nasal spray.
Miller VM; Lewis DA; Rud KS; Offord KP; Croghan IT; Hurt RD
J Clin Pharmacol; 1998 Jan; 38(1):22-7. PubMed ID: 9597555
[TBL] [Abstract][Full Text] [Related]
11. Randomised controlled trial of nasal nicotine spray in smoking cessation.
Sutherland G; Stapleton JA; Russell MA; Jarvis MJ; Hajek P; Belcher M; Feyerabend C
Lancet; 1992 Aug; 340(8815):324-9. PubMed ID: 1353803
[TBL] [Abstract][Full Text] [Related]
12. Effect of grapefruit juice on cytochrome P450 2A6 and nicotine renal clearance.
Hukkanen J; Jacob P; Benowitz NL
Clin Pharmacol Ther; 2006 Nov; 80(5):522-30. PubMed ID: 17112808
[TBL] [Abstract][Full Text] [Related]
13. Nicotine nasal spray for smoking cessation: pattern of use, side effects, relief of withdrawal symptoms, and cotinine levels.
Hurt RD; Dale LC; Croghan GA; Croghan IT; Gomez-Dahl LC; Offord KP
Mayo Clin Proc; 1998 Feb; 73(2):118-25. PubMed ID: 9472993
[TBL] [Abstract][Full Text] [Related]
14. Dose-related cardiovascular and endocrine effects of transdermal nicotine.
Zevin S; Jacob P; Benowitz NL
Clin Pharmacol Ther; 1998 Jul; 64(1):87-95. PubMed ID: 9695723
[TBL] [Abstract][Full Text] [Related]
15. Differences between smokers and never-smokers in sensitivity to nicotine: a preliminary report.
Pomerleau OF; Hariharan M; Pomerleau CS; Cameron OG; Guthrie SK
Addiction; 1993 Jan; 88(1):113-8. PubMed ID: 8448500
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the nicotine pharmacokinetics of Nicoderm (nicotine transdermal system) and half-hourly cigarette smoking.
Gupta SK; Hwang SS; Causey D; Rolf CN; Gorsline J
J Clin Pharmacol; 1995 Oct; 35(10):985-9. PubMed ID: 8568016
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of nicotine: addiction and therapeutics.
Benowitz NL
Annu Rev Pharmacol Toxicol; 1996; 36():597-613. PubMed ID: 8725403
[TBL] [Abstract][Full Text] [Related]
18. CYP2A6 genotype and the metabolism and disposition kinetics of nicotine.
Benowitz NL; Swan GE; Jacob P; Lessov-Schlaggar CN; Tyndale RF
Clin Pharmacol Ther; 2006 Nov; 80(5):457-67. PubMed ID: 17112802
[TBL] [Abstract][Full Text] [Related]
19. Sex-based and hormonal contraception effects on the metabolism of nicotine among adolescent tobacco-dependent smokers.
Berlin I; Gasior MJ; Moolchan ET
Nicotine Tob Res; 2007 Apr; 9(4):493-8. PubMed ID: 17454704
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of tobacco smoking and nasal nicotine.
Teter CJ; Asfaw B; Ni L; Lutz M; Domino EF; Guthrie SK
Eur J Clin Pharmacol; 2002 Aug; 58(5):309-14. PubMed ID: 12185553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
